Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3535 Olentangy River Rd
Columbus, OH 43214Phone+1 614-566-4945Fax+1 614-263-1056
Education & Training
Cleveland Clinic FoundationResidency, Pathology-Anatomic and Clinical, 2003 - 2007
The University of Toledo College of MedicineClass of 2003
Certifications & Licensure
OH State Medical License 2003 - 2025
MA State Medical License 2008 - 2012- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Hudson Valley Magazine Castle Connolly, 2010-2013
Publications & Presentations
PubMed
- 9 citationsPathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations.David A. Barrington, Ashley S. Felix, Rieham Owda, Adrian A. Suarez, David W. Cohen
Surgical Oncology. 2020-09-01 - 49 citationsProspective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ult...Floor J. Backes, David W. Cohen, Ritu Salani, David E. Cohn, David M. O'Malley
Gynecologic Oncology. 2019-06-01 - 5 citationsLoss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition.Douglas M Spaeth-Cook, Mark G. Burch, Robin Belton, Bryce Demoret, Nicholas Grosenbacher
Oncotarget. 2018-11-02
Journal Articles
- Loss of TXNIP Enhances Peritoneal Metastasis and Can Be Abrogated by Dual TORC1/2 InhibitionDavid Cohen, James L Chen, John L Hays, Oncotarget
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
